Technology
Sarasin shuns FAANGs in search for 'next $1trn company' with Digital Opps launch
Sarasin & Partners has expanded its thematic range with the launch of a Digital Opportunities fund, which has shunned the mega-cap tech stocks in favour of a concentrated portfolio of emerging small- and mid-cap contenders in efforts to "find the next...
Why Scottish Mortgage is a value trust and not a tech trust
Clearing up misconceptions
Octopus to acquire wealth technology business for £10m
'Natural evolution'
Six of the biggest market disruptors investors should watch
Finding market leaders in the NEXT economy
Advice rewired: Do robo-advisers dream of actual profits?
Long live robo-advice
Update: Facebook subsidiary Calibra to introduce digital wallet for new digital currency
Slated for 2020 launch
ASI, Kames, Legg Mason and Merian team up to launch FNZ-backed blockchain infrastructure
Main register for fund transactions
Calling all green tech innovators: Last chance to apply for BusinessGreen pitch event
Deadline for applications: 22 February
Fidelity launches Global Communications fund to take advantage of sector shake-up
Reclassification last September
Calastone targets 'biggest industry transfer' in move to blockchain
Aiming to save £3.4bn
Are we heading for another late-1990s tech bubble?
Value comes from cash flows
How will fintech impact the asset management industry?
A rapidly growing area of the financial industry
Megatrends: Understanding the tech revolution
Partner Insight: How have companies like Amazon contributed to the megatrend tech revolution?
Coutts' Syed: Those not looking at blockchain are burying their heads in the sand
Too much fragmentation in wealth management
Tech stocks: Responding to the change in market leadership
Seeing increasing dispersion
Biotech in the fight against cancer
INDUSTRY VOICE: Big players in the healthcare sector are desperate to differentiate their approved 'checkpoint inhibitors' (a drug that unleashes an immune system attack on cancer cells) by combining their use with conventional chemotherapy or other new...
Update: Invesco buys advisory tech firm Intelliflo
Previously owned by European private equity investor
Why TSB's technology debacle should be a wake-up call for wealth managers
Investing in new systems crucial
Which technology companies are most ESG-friendly?
Focus on renewable energy
Ex-BlackRock trio quit to launch ESG blockchain fund
Tackling gender equality, hunger and education issues
Asset managers need to be 'ahead of the curve' amid transformational digital environment
Legacy technology remains primary obstacle
Most read
